Format

Send to

Choose Destination
Int J Cancer. 2018 Nov 25. doi: 10.1002/ijc.32013. [Epub ahead of print]

Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

Author information

1
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290, Helsinki, Finland.
2
Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia.
3
Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, 194100, Russia.
4
Department of Oncology, I.I. Mechnikov North-Western Medical University, St.-Petersburg, 191015, Russia.
5
Department of Oncology, St.-Petersburg State University, St.-Petersburg, 199034, Russia.
PMID:
30474109
DOI:
10.1002/ijc.32013

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center